T2 Biosystems to Report Second Quarter 2020 Financial Results on August 11, 2020

Rhea-AI Summary

T2 Biosystems (NASDAQ: TTOO) announced it will release its second quarter 2020 financial results on August 11, 2020, after market close. A conference call will follow at 4:30 p.m. ET, where management will discuss the results. Interested investors can access the live and archived webcast on T2's website. The company specializes in the rapid detection of sepsis-causing pathogens and offers various diagnostic panels, powered by its proprietary T2 Magnetic Resonance technology. The firm is also advancing its product pipeline with new detection panels.

Positive

• T2 Biosystems is a leader in rapid detection of sepsis-causing pathogens.
• The company has an active product pipeline, including future products like T2Cauris and T2Lyme panels.

Negative

• None.

LEXINGTON, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2020 after market close on Tuesday, August 11, 2020. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com, on the Investors page in the Events & Presentations section. The call will also be available by dialing 877-407-9208 (U.S.) or 201-493-6784 (International) five to ten minutes prior to the start time.

About T2 Biosystems:
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Candida® Panel, the T2Bacteria® Panel, the T2Resistance™ Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Cauris™ Panel, and T2Lyme ™ Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, as well as biothreat pathogens.

Media Contact:
Gina Kent, Vault Communications
gkent@vaultcommunications.com
610-455-2763

Investor Contact:
Philip Trip Taylor, Gilmartin Group
philip@gilmartinIR.com
415-937-5406

FAQ

When will T2 Biosystems report its Q2 2020 financial results?

T2 Biosystems will report its second quarter financial results on August 11, 2020, after market close.

What time is the T2 Biosystems conference call for Q2 2020 results?

The conference call for discussing Q2 2020 results will begin at 4:30 p.m. Eastern Time on August 11, 2020.

How can I listen to the T2 Biosystems Q2 2020 results call?

Investors can listen to the call via a live and archived webcast on T2 Biosystems' website.

What products does T2 Biosystems offer?

T2 Biosystems offers several diagnostic panels, including T2Candida, T2Bacteria, and T2SARS-CoV-2 panels, powered by T2 Magnetic Resonance technology.